Dr. Sievert Weiss is a physician, co-founder, and medical director of AMBOSS. Since its founding, he and an interdisciplinary team have pursued the goal of making medical knowledge available where it is needed in everyday clinical practice.
For more than 20 years, JPT Peptide Technologies has been producing peptides for scientific purposes and the pharmaceutical industry in Berlin. In the year 2009, the biotech company was acquired by Mainz-based BioNTech SE and has since grown…
In the study, [68Ga]Ga-Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity for identifying unilateral aldosterone-producing adenomas compared with adrenal vein sampling (AVS) and surgical outcomes
The…
Apply now until April 15, 2026!
Europe's leading digital health platform closes Series D round to expand access to chronic care, led by long-term, impact-focused healthcare investors.
Apply now!
The appliedAI Institute for Europe gGmbH is inviting AI startups to take part in the German AI Startup Landscape 2026 – an annual overview that helps make the diversity of Germany’s AI ecosystem visible.
Trial Results Support Transition into Late-Stage Development with Program Expected to be Phase 2b/3-ready in H2 2026
Founded in 2017, Recare has built an impressive presence in the German healthcare market. The company currently serves two-thirds of German hospitals and more than 26,000 nursing staff with its Software-as-a-Service platform that digitally simplifies…
- Extending BIOTRONIK’s DX Technology to leadless pacing
- World’s first leadless pacemaker to deliver AV synchronous pacing using atrial electrical far-field signals
